Catalyst Wire Dossier Catalyst Wire Dossier

BELRAPZO

BENDAMUSTINE HYDROCHLORIDE · Eagle Pharmaceuticals, Inc
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BELRAPZO, covering 2018-05-15 to 2024-01-11. Get the full timeline:

Most recent: FDA Approved: BELRAPZO — Supplemental Application (Eagle Pharmaceuticals, Inc)

See pricing